Medifast
MED
140 hedge funds and large institutions have $175M invested in Medifast in 2024 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 30 increasing their positions, 54 reducing their positions, and 39 closing their positions.
120% more call options, than puts
Call options by funds: $11.1M | Put options by funds: $5.04M
11% less funds holding
Funds holding: 158 → 140 (-18)
11.57% less ownership
Funds ownership: 95.33% → 83.76% (-12%)
23% less capital invested
Capital invested by funds: $228M → $175M (-$52.1M)
44% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 39
44% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 54
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
QOP
Quinn Opportunity Partners
Charlottesville,
Virginia
|
+$2.25M |
| 2 |
Goldman Sachs
New York
|
+$2.22M |
| 3 |
Prudential Financial
Newark,
New Jersey
|
+$1.42M |
| 4 |
Renaissance Technologies
New York
|
+$917K |
| 5 |
BlackRock
New York
|
+$904K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$7.96M |
| 2 |
HF
HRT Financial
New York
|
-$2.52M |
| 3 |
D.E. Shaw & Co
New York
|
-$2.49M |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$2.29M |
| 5 |
Jane Street
New York
|
-$1.96M |
MED Hedge Fund Activity: Q3 2024 in Review
140 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q3 2024, worth a combined $175M — down 23% from $228M a quarter earlier.
Sellers outnumbered buyers: 39 funds closed out of MED and 22 opened new positions — a net loss of 17 holders — while 54 trimmed existing stakes and 30 added.
The largest buyer was Quinn Opportunity Partners, opening a new position worth an estimated $2.25M. The largest seller was Millennium Management, cutting an estimated $7.96M.
- 140 institutional investors held Medifast (MED) as of Q3 2024, down from 158 in Q2 2024.
- Funds reported $175M of Medifast stock for Q3 2024, down 23% quarter-over-quarter.
- 22 funds opened new Medifast positions in Q3 2024 and 39 closed out, a net change of -17 holders.
- The largest Medifast buyer in Q3 2024 was Quinn Opportunity Partners, an estimated $2.25M added.
- The largest Medifast seller in Q3 2024 was Millennium Management, an estimated $7.96M sold.
Based on aggregated 13F filings for Q3 2024.